Nebraska Methodist Hospital chooses Elekta Synergy

Nebraska Methodist Hospital recently ordered an Elekta Synergy platform, one component of the facility's $13.5 million expansion of its oncology and neurosurgery programs.

The technology will enable doctors at the Omaha facility to obtain images of patients before their treatment, allowing them to visualize tumors at the point of treatment to more precisely target tumors with radiation beams.

Elekta Synergy is a linear accelerator-based system designed for image-guided radiation therapy (IGRT), which guides radiation delivery to a tumor, while sparing healthy tissues.

Elekta currently is taking orders for and installing Elekta Synergy linear accelerators at cancer clinics in the United States and Europe.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup